Mobile Critical Care Recovery Program (m-CCRP) for Acute Respiratory Failure (ARF) Survivors

项目概要/摘要： 急性呼吸衰竭（ARF）的幸存者遭受功能性呼吸衰竭形式的长期发病。 残疾、认知障碍、重度或轻度抑郁和焦虑。这些并发症会对 这些ARF幸存者的生活质量，干扰他们的康复，导致长期残疾， 每个急性肾衰幸存者350万美元。这些后遗症和伴随的发病率现在已经被 重症监护后综合征（PICS）。虽然有社区资源， 康复服务，但由于分散的医疗保健提供过程， 高不可攀 印第安纳州大学老龄化研究中心（IUCAR）拥有20多年的经验， 利用与初级保健和其他保健相结合的保健协调员进行跨学科的协作保健 特产这些护理模式改善了对患有痴呆症等慢性疾病的老年人的护理， 抑郁症和功能障碍，通过护理协调克服零散的护理。 目前的提案被称为急性移动的重症监护恢复计划（m-CCRP）， 呼吸衰竭（ARF）幸存者建立在IUCAR提供协作护理的经验。的 m-CCRP旨在通过一项随机对照试验，利用移动的 护理协调员。本试验有以下具体目的：1）评价m-CCRP在改善 ARF幸存者的健康相关生活质量。2)评价m-CCRP改善认知功能的疗效， ARF幸存者的生理和心理功能。3)评价m-CCRP在降低 ARF幸存者利用保健服务的情况。 这项研究是创新的，因为它促进了一种新的跨学科干预ARF幸存者 具有持续反馈和快速适应性。这项试验的结果将是重要的和基础性的 在整个美国医疗保健系统中传播/实施该计划，以实现以下目标： 更好的健康，更好的护理，以及减少医疗保健利用，正如医疗保健研究所所提倡的那样。

Project Summary/Abstract: Survivors of Acute Respiratory Failure (ARF) suffer from long-term morbidity in the form of functional disability, cognitive impairment, major or minor depression, and anxiety. These complications negatively impact the quality of life of these ARF survivors, interfere with their recovery, lead to long-term disability, and cost the health care system $3.5 million per ARF survivor. These sequelae and attendant morbidity have now been designated as the post-intensive care syndrome (PICS). Although there are community resources and rehabilitation services, but due to a fragmented healthcare delivery process, a meaningful recovery is unattainable. Indiana University Center for Aging Research (IUCAR) has over 20 years of experience to provide interdisciplinary, collaborative care utilizing care coordinators integrated with primary care and other specialties. These care models have improved care of elderly with chronic disease states such as dementia, depression, and functional impairment by overcoming fragmented care through care coordination. The current proposal termed the Mobile Critical Care Recovery Program (m-CCRP) for Acute Respiratory Failure (ARF) Survivors builds from the IUCAR's experience of delivering collaborative care. The m-CCRP aims to improve the recovery of ARF survivors through a randomized controlled trial utilizing a mobile care coordinator. The trial has the following specific aims: 1) Evaluate the efficacy of m-CCRP in improving the health related quality of life of ARF survivors. 2) Evaluate the efficacy of m-CCRP in improving the cognitive, physical, and psychological function of ARF survivors. 3) Evaluate the efficacy of m-CCRP in reducing the health-care utilization by ARF survivors. This research is innovative as it promotes a novel interdisciplinary intervention among ARF survivors with continuous feedback and rapid adaptability. The outcomes of this trial will be significant and foundational for dissemination/ implementation of the program across the US health care system to achieve the aims of better health, better care, and reduced health care utilization as promoted by the Institute of Healthcare.